scholarly journals Polysaccharide-Enriched Fraction from Amillariella Mellea Fruiting Body Improves Insulin Resistance

Molecules ◽  
2018 ◽  
Vol 24 (1) ◽  
pp. 46 ◽  
Author(s):  
Siwen Yang ◽  
Yuhan Meng ◽  
Jingmin Yan ◽  
Na Wang ◽  
Zhujun Xue ◽  
...  

Despite the edible fungus Amillariella mellea possessing a variety of biological activities, its effects on diabetes are still unclear. Polysaccharides are the main bioactive ingredients. In order to destroy the cell wall to obtain more polysaccharides, we used NaOH solution to extract Amillariella mellea fruiting bodies. The alkali extraction (AAMP) was identified as a polysaccharide-enriched fraction. Using type 2 diabetic rats induced by co-treatment of a high fat diet (HFD) and dexamethasone (DEX), we evaluated the hypoglycemic effects of AAMP. The results showed that oral administration of a high dose of AAMP markedly lowered fasting blood glucose, improving glucose intolerance and insulin resistance. AAMP also enhanced the level of LPL and the expressions of two critical lipases ATGL and HSL, leading to a decrease of serum triglyceride. In addition, AAMP specifically suppressed the expression of SREBP-1c, resulting in AAMP observably inhibiting lipid accumulation in the liver. These findings demonstrated that the improvement of AAMP on HFD/DEX-induced insulin resistance was correlated with its regulation of lipid metabolism. Our results indicated that AAMP could be a novel natural drug or health food used for the treatment of diabetes.

2020 ◽  
Vol 10 (2) ◽  
pp. 129-139
Author(s):  
Uchenna Collins Abonyi ◽  
Moses A Omoiri ◽  
Peter A Akah

This study evaluated the anti-diabetic properties of the methanol extract and fractions of Dennettia tripetala leaves in alloxan diabetic rats. The crude  methanol extract (ME), n-hexane  (NF), ethyl acetate  (EAF), butanol  (BF) and water  (WF) fractions,  were tested for anti-diabetic activity in  alloxan-induced diabetic mice. The extracts and its fractions were screened for phytochemical constituents. Glibenclamide was used as the standard anti-diabetic treatment   Fasting blood glucose (FBG) levels were determined using a glucometer.  Lipid profile parameters were also assessed.  Histopathological examination of the pancreas was performed. The presence of glycosides, saponins, reducing sugars, fats and oil, alkaloids, carbohydrates, flavonoids, proteins and tannins were detected in ME, and the fractions. Treatment of the rats with the extract and its fractions reduced FBG levels significantly (p < 0.05) within 10 hours of acute treatment and 14 days short term treatment.  The highest reduction was by the crude extract,( ME 500 mg/kg) with percentage reduction of 62.89 %. The study revealed  significant (p < 0.05) reductions in serum triglyceride, serum cholesterol and LDL levels  by the extracts and its fractions  while a significant (p <  0.05) increase  in HDL levels was evident .  The effect of the extract and fractions on body weight indicated a moderate weight gain. Treatment with high dose of the extract and fractions (500 mg/kg) resulted in marked rejuvenation of the pancreatic β cells. The results of this study suggest that the leaves of Dennetia tripetala are endowed with potent anti-diabetic and antilipidemic properties.   Keywords: Dennetia tripetala, Antidiabetic, Alloxan, Lipid profile, Histopathplogy.


2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Jianping Chen ◽  
Xiaoyan Liu ◽  
Zhonggui Li ◽  
Airong Qi ◽  
Ping Yao ◽  
...  

The fruits ofZiziphus jujuba, known as jujube or Chinese date, are being consumed all around the world because of their health benefits, as both food and herbal medicine. Traditionally, one of the main functions of jujube, as described in herbal medicine, is to benefit our brain by calming down the mind and improving quality of sleep. Here, the activities of jujubes on nervous system are summarized and discussed. Jujube possesses neuroprotective activities, including protecting neuronal cells against neurotoxin stress, stimulating neuronal differentiation, increasing expression of neurotrophic factors, and promoting memory and learning. Flavonoid, cAMP, and jujuboside could be the potential bioactive ingredients to account for the aforesaid biological activities. These findings imply that jujube is a potential candidate for development of health supplements for prevention and/or treatment of neurological diseases.


2018 ◽  
Vol 38 (2) ◽  
Author(s):  
Qian Zhang ◽  
Xinhua Xiao ◽  
Jia Zheng ◽  
Ming Li ◽  
Miao Yu ◽  
...  

Increasing evidence shows that diabetes causes cardiac dysfunction. We hypothesized that a glucagon-like peptide-1 (GLP-1) analog, liraglutide, would attenuate cardiac dysfunction in diabetic rats. A total of 24 Sprague–Dawley (SD) rats were divided into two groups fed either a normal diet (normal, n=6) or a high-fat diet (HFD, n=18) for 4 weeks. Then, the HFD rats were injected with streptozotocin (STZ) to create a diabetic rat model. Diabetic rats were divided into three subgroups receiving vehicle (diabetic, n=6), a low dose of liraglutide (Llirag, 0.2 mg/kg/day, n=6), or a high dose of liraglutide (Hlirag, 0.4 mg/kg/day, n=6). Metabolic parameters, systolic blood pressure (SBP), heart rate (HR), left ventricular (LV) function, and whole genome expression of the heart were determined. Diabetic rats developed insulin resistance, increased blood lipid levels and oxidative stress, and impaired LV function, serum adiponectin, nitric oxide (NO). Liraglutide improved insulin resistance, serum adiponectin, NO, HR, and LV function and reduced blood triglyceride (TG), total cholesterol (TC) levels, and oxidative stress. Moreover, liraglutide increased heart nuclear receptor subfamily 1, group H, member 3 (Nr1h3), peroxisome proliferator activated receptor (Ppar) α (Pparα), and Srebp expression and reduced diacylglycerol O-acyltransferase 1 (Dgat) and angiopoietin-like 3 (Angptl3) expression. Liraglutide prevented cardiac dysfunction by activating the PPARα pathway to inhibit Dgat expression and oxidative stress in diabetic rats.


2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Wenting Lin ◽  
Wenxiang Wang ◽  
Dongdong Liao ◽  
Damiao Chen ◽  
Pingping Zhu ◽  
...  

This study investigated the effects of polysaccharides fromEnteromorpha prolifera(PEP) on glucose metabolism in a rat model of diabetes mellitus (DM). PEP (0, 150, 300, and 600 mg/kg) was administered intragastrically to rats for four weeks. After treatment, fasting blood glucose (FBG) and insulin (INS) levels were measured, and the insulin sensitivity index (ISI) was calculated. The morphopathological changes in the pancreas were observed. Serum samples were collected to measure the oxidant-antioxidant status. The mRNA expression levels of glucokinase (GCK) and insulin receptor (InsR) in liver tissue and glucose transporter type 4 (GLUT-4) and adiponectin (APN) in adipose tissue were determined. Compared with the model group, the FBG and INS levels were lower, the ISI was higher, and the number of isletβ-cells was significantly increased in all the PEP groups. In the medium- and high-dose PEP groups, MDA levels decreased, and the enzymatic activities of SOD and GSH-Px increased. The mRNA expression of InsR and GCK increased in all the PEP groups; APN mRNA expression increased in the high-dose PEP group, and GLUT-4 mRNA expression increased in adipose tissue. These findings suggest that PEP is a potential therapeutic agent that can be utilized to treat DM.


2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Nana Wang ◽  
Tiegang Li ◽  
Ping Han

In the clinical setting, given the potential adverse effects of thiazolidinediones and biguanides, we often have difficulty in treatment that no other insulin sensitizers are available for use in type 2 diabetic mellitus (T2DM) patients. Tianmai Xiaoke Pian (TMXKP) is a traditional Chinese medicine tablet, which is comprised of chromium picolinate, Tianhuafen, Maidong, and Wuweizi. To understand its mechanism of action on insulin resistance, TMXKP (50 mg/kg orally) was tested in T2DM rats (induced by a high-fat diet and streptozotocin). Eight weeks later, fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT) were performed. Area under the curve (AUC) and homeostatic model assessment of insulin resistance (HOMA-IR) were calculated, and PI3-K/AKT signal pathway-related genes and proteins were tested by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis in muscle, adipose, and liver tissues, respectively. TMXKP significantly reduced FBG, OGTT, AUC, and HOMA-IR in diabetic ratsP<0.05. Furthermore, we also observed that TMXKP could significantly decreaseIRS-1,IRS-2,PI3-K p85α, andAKT2gene expression and also IRS-1, IRS-2, PI3-K, AKT2, and p-AKT2 protein expression levelsP<0.05in diabetic rats. These findings confirm that TMXKP can alleviate insulin resistance in T2DM rats through the PI3K/AKT pathway. Thus TMXKP appears to be a promising insulin sensitizer.


2015 ◽  
Vol 17 (1) ◽  
pp. 86-91 ◽  
Author(s):  
Md Siddiqul Islam ◽  
Salma Parvin ◽  
Md Nasir Uddin ◽  
Md Abdul Mazid

The decoctions of Coccinea grandis (L.) and Centella asiatica (L.) leaves were evaluated for their antidiabetic and antioxidant potentials in alloxan-induced rat model and by DPPH free radical scavenging assay, respectively. Graded doses of the decoctions administered to normal and experimental diabetic rats for two weeks showed significant reduction in fasting blood glucose levels in the normal as well as in treated diabetic animals. The experiment showed 188.42 ± 1.2 mg/dl glucose and 117.78 ± 11.2 mg/dl cholesterol levels for C. grandis, while 187.23 ± 0.8 mg/dl glucose and 116.14 ± 1.5 mg/dl cholesterol for C. asiatica. Although, the decoctions produced significant effect on serum urea level, the total protein and liver enzymes (SGOT and SGPT) were found to be normal. Acute toxicity studies showed that both the decoctions were safe at 2-fold high dose when compared with the commonly used antidiabetic dose. Total phenolic contents in decoctions were found to be 12.45±0.52 and 8.32 ± 0.31 for C. grandis and C. asiatica, respectively while DPPH free radical scavenging assay showed the IC50 values of 0.14 ± 0.001 for C. grandis and 0.17± 0.001 for C. asiatica. Our current studies for the first time, justified the use of decoctions of the leaves of C. grandis and C. asiatica for treating diabeties, hyperlipaedemia and atherogenic lesion in the indigenous system of medicine. DOI: http://dx.doi.org/10.3329/bpj.v17i1.22322 Bangladesh Pharmaceutical Journal 17(1): 86-91, 2014


2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Wujie Cai ◽  
Lijing Yu ◽  
Yu Zhang ◽  
Li Feng ◽  
Siyuan Kong ◽  
...  

The aim of this study was to assay the effects ofCoreopsis tinctoriaNutt. flower extracts on hyperglycemia of diet-induced obese mice and the underlying mechanisms.Coreopsis tinctoriaflower was extracted with ethanol and water, respectively. The total phenol, flavonoid levels, and the constituents of the extracts were measured. For the animal experiments, C57BL/6 mice were fed with a chow diet, high-fat diet, or high-fat diet mixed with 0.4% (w/w) water and ethanol extracts ofCoreopsis tinctoriaflower for 8 weeks. The inhibitory effects of the extracts onα-glucosidase activity and the antioxidant properties were assayedin vitro. We found that the extracts blocked the increase of fasting blood glucose, serum triglyceride (TG), insulin, leptin, and liver lipid levels and prevented the development of glucose tolerance impairment and insulin resistance in the C57BL/6 mice induced by a high-fat diet. The extracts inhibitedα-glycosidase activity and increased oxidant activityin vitro. In conclusion,Coreopsis tinctoriaflower extracts may ameliorate high-fat diet-induced hyperglycemia and insulin resistance. The underling mechanism may be via the inhibition ofα-glucosidase activity. Our data indicate thatCoreopsis tinctoriaflower could be used as a beverage supplement and a potential source of drugs for treatment of diabetics.


2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Mingshun Zhang ◽  
Shuna Sun ◽  
Ning Tang ◽  
Wei Cai ◽  
Linxi Qian

Alkylglycerols (AKGs) from shark liver oil (SLO) were demonstrated to have strong potency to stimulate immune response. However, no study has been conducted on the effects of AKGs on diet-induced obesity and metabolic inflammatory disorder. The purpose of the present study was to investigate the effect of two AKGs isoforms on obesity and insulin resistance in mice fed high-fat (HF) diet. Forty-eight C57BL/6 mice were divided into normal, HF,HF+20 mg/kg selachyl alcohol (SA),HF+200 mg/kg SA,HF+20 mg/kg batyl alcohol (BA), andHF+200 mg/kg BA groups. Body weight, fasting glucose, lipids, insulin and leptin levels, serum IL-1β, and TNF-αlevels were compared among different groups. Our results showed that high-dose SA decreased body weight, serum triglyceride, cholesterol, fasting glucose level, insulin level, and serum leptin level of the HF fed mice, while high-dose BA increased fasting insulin level of the HF fed mice. Pretreatment of primary adipocytes with 10 μM SA or BA differentially modulates LPS-mediated MAPK and NF-κB signaling. Our study demonstrated that oral administration of AKGs has differential effects on HF-induced obesity and metabolic inflammatory disorder in mice.


Author(s):  
Laura M Pompano ◽  
Erick Boy

ABSTRACT No meta-analysis has examined the effect of dose and duration of zinc interventions on their impact on risk factors for type 2 diabetes (T2D) or cardiovascular disease (CVD). This study aimed first to compare the effects of zinc interventions dichotomized as low versus high dose (&lt;25 mg/d and ≥25 mg/d, respectively) and short versus long duration (&lt;12 wk and ≥12 wk, respectively) on risk factors for T2D and CVD. Second, it discusses the results from the low-dose and long-duration meta-analyses as a foundation for understanding what impact a zinc-biofortification intervention could have on these risk factors. The PubMed and Cochrane Review databases were searched through January 2020 for full-text, human studies providing zinc supplements (alone) at doses ≤75 mg/d and a placebo. Data on study and sample characteristics and several T2D and CVD risk factors were extracted. There were 1042 and 974 participants receiving zinc and placebo, respectively, from 27 studies. Low-dose zinc supplementation (&lt;25 mg/d) significantly benefited fasting blood glucose, insulin resistance, triglycerides, total cholesterol, and LDL cholesterol. High-dose zinc supplementation (≥25 mg/d) benefited glycated hemoglobin and insulin resistance. Short-duration interventions (&lt;12 wk) benefited fasting blood glucose, insulin resistance, and triglycerides, while long-duration studies (≥12 wk) benefited fasting blood glucose, triglycerides, and total and LDL cholesterol. Effect sizes for low-dose and long-duration interventions were of equal or greater magnitude to those from high-dose or short-duration interventions. Low-dose and long-duration zinc supplementation each improved more risk factors for T2D and CVD than high-dose and short-duration interventions, respectively. It is currently unknown whether low doses of zinc delivered over long durations via a biofortified crop would similarly impact these risk factors. However, this review suggests that low-dose, long-duration zinc intake from supplements, and potentially biofortification, can benefit risk factors for T2D and CVD.


Author(s):  
Igwe Gloria ◽  
Nsirim Nduka ◽  
G. Tamunoemine Davies ◽  
Brown Holy

Diabetes Mellitus is a disease of public health concern which is caused by pancreatic defect in insulin secretion or failure of the receptor cells to effectively utilize secreted insulin. Diabetes account for 2-3% death in the poorest countries hence the need for alternative control measure. This stud evaluated the hypoglycemic and hepatorenal effect of Ocimium gratissimium and glibenclamide in alloxan induced diabetic rats. Twenty- four rats were randomly divided into 6 groups of 4 animals in each group (1,2,3,4,5 & 6), groups 2,3,4,5 & 6 were induced diabetes intraperitoneally with 150 mg\kg alloxan (Sigma Ltd), diabetes was confirmed by fasting blood glucose of >10.0mmol/L. Groups 3,4,5 & 6 were subsequently treated with 400 mg/kg of extract, 5mg glibenclamide, 800 mg/kg of extract, 400 mg/kg extract combined with 5mg glibenclamide respectively. Blood glucose, hepatic function variables (Aspartate aminotransferase (AST), Alanine aminotransferase(ALT), Total bilirubin (TB) and renal parameters Sodium (Na+), Potassium (K+), Urea were analyzed. The result shows an increase in glucose, hepatic and renal parameters in diabetic induced groups which was significantly reduced in a dose dependent manner in the diabetic treated groups, the high dose of the extract (800mg/kg) was more effective in blood glucose reduction than the standard antidiabetic drug, (5mg glibenclamide). However, 5mg glibenclamide was found to be more effective in blood glucose reduction than the low dose (400mg/kg) extract, the combination of 5mg glibenclamide and 400mg/kg was found to be more effective in blood glucose reduction than the low dose extract. A significant increase was observed in the Total bilirubin and urea parameters of the high dose (800mg/kg) of the extract treated groups and in the combined group (400 mg/kg+5 mg glibenclamide). When compared to the low dose extract group(400mg/kg). Low dose ocimium gratissimium potentiates 5mg glibenclamide in blood glucose reduction. Ocimium gratissimium and glibenclamide decreased blood glucose and ameliorates alloxan induced hepatic and renal damage. The use of the high dose of the extract and the use of the combination of the drug (5mg glibenclamide) and the low dose of the extract in diabetes management may be detrimental to the liver and kidney according to this study.


Sign in / Sign up

Export Citation Format

Share Document